Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04566393
Title Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors xCures
Age Groups: child | adult | senior
Covered Countries USA

Additional content available in CKB BOOST